BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34090299)

  • 1. ASTHMA IN A PATIENT WITH COVID-19: DOES IT PROTECT OR INCREASE THE RISKS?
    Kochuieva MN; Psarova VH; Shklyar SP; Oparin AA
    Wiad Lek; 2021; 74(5):1245-1249. PubMed ID: 34090299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma in the era of SARS CoV-2 virus.
    Bakakos A; Krompa A
    J Asthma; 2022 Aug; 59(8):1501-1508. PubMed ID: 34112029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19.
    Gao YD; Agache I; Akdis M; Nadeau K; Klimek L; Jutel M; Akdis CA
    Int Immunol; 2022 Mar; 34(4):177-188. PubMed ID: 34788827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asthma and COVID-19: Emphasis on Adequate Asthma Control.
    Nassoro DD; Mujwahuzi L; Mwakyula IH; Possi MK; Lyantagaye SL
    Can Respir J; 2021; 2021():9621572. PubMed ID: 34457096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma and COVID-19: lessons learned and questions that remain.
    Howell D; Verma H; Ho KS; Narasimhan B; Steiger D; Rogers L
    Expert Rev Respir Med; 2021 Nov; 15(11):1377-1386. PubMed ID: 34570678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19.
    Eggert LE; He Z; Collins W; Lee AS; Dhondalay G; Jiang SY; Fitzpatrick J; Snow TT; Pinsky BA; Artandi M; Barman L; Puri R; Wittman R; Ahuja N; Blomkalns A; O'Hara R; Cao S; Desai M; Sindher SB; Nadeau K; Chinthrajah RS
    Allergy; 2022 Jan; 77(1):173-185. PubMed ID: 34080210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Asthma and COPD management during the COVID-19 pandemic].
    Daccord C; Touilloux B; Von Garnier C
    Rev Med Suisse; 2020 May; 16(692):933-938. PubMed ID: 32374540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe asthma in the era of COVID-19: A narrative review.
    Gaspar-Marques J; van Zeller M; Carreiro-Martins P; Chaves Loureiro C
    Pulmonology; 2022; 28(1):34-43. PubMed ID: 34053902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of asthma in patients hospitalized for pneumonia associated to SARS-CoV-2 infection].
    Paz-Velarde BA; Arellano-Arteaga KJ; Bedolla-Pulido A; Morales-Romero J; Rodríguez-Lizola JM; Bedolla-Barajas M
    Rev Alerg Mex; 2023 May; 70(1):1-7. PubMed ID: 37566750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia: A single-center, retrospective study.
    Lombardi C; Roca E; Bigni B; Cottini M; Passalacqua G
    Ann Allergy Asthma Immunol; 2020 Dec; 125(6):707-709. PubMed ID: 32745609
    [No Abstract]   [Full Text] [Related]  

  • 12. Considerations for asthma management and viral transmission in the era of COVID-19.
    Pitlick MM; Joshi AY
    Allergy Asthma Proc; 2021 Jan; 42(1):93-96. PubMed ID: 33357281
    [No Abstract]   [Full Text] [Related]  

  • 13. Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease.
    Cashman DP
    Med Hypotheses; 2020 Nov; 144():110027. PubMed ID: 32758873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 in patients with severe asthma using biological agents.
    Aksu K; Demir Ş; Topel M; Yeşilkaya S; Ateş H; Koca Kalkan İ; Öncül A; Çuhadar Erçelebi D; Türkyılmaz S
    Tuberk Toraks; 2021 Sep; 69(3):433-436. PubMed ID: 34581170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma in the era of COVID-19.
    Assaf S; Stenberg H; Jesenak M; Tarasevych SP; Hanania NA; Diamant Z
    Respir Med; 2023 Nov; 218():107373. PubMed ID: 37567514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.
    Song J; Zeng M; Wang H; Qin C; Hou HY; Sun ZY; Xu SP; Wang GP; Guo CL; Deng YK; Wang ZC; Ma J; Pan L; Liao B; Du ZH; Feng QM; Liu Y; Xie JG; Liu Z
    Allergy; 2021 Feb; 76(2):483-496. PubMed ID: 32716553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden.
    Papadopoulos NG; Custovic A; Deschildre A; Mathioudakis AG; Phipatanakul W; Wong G; Xepapadaki P; Agache I; Bacharier L; Bonini M; Castro-Rodriguez JA; Chen Z; Craig T; Ducharme FM; El-Sayed ZA; Feleszko W; Fiocchi A; Garcia-Marcos L; Gern JE; Goh A; Gómez RM; Hamelmann EH; Hedlin G; Hossny EM; Jartti T; Kalayci O; Kaplan A; Konradsen J; Kuna P; Lau S; Le Souef P; Lemanske RF; Mäkelä MJ; Morais-Almeida M; Murray C; Nagaraju K; Namazova-Baranova L; Garcia AN; Yusuf OM; Pitrez PMC; Pohunek P; Pozo Beltrán CF; Roberts GC; Valiulis A; Zar HJ;
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2592-2599.e3. PubMed ID: 32561497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does asthma affect morbidity or severity of COVID-19?
    Matsumoto K; Saito H
    J Allergy Clin Immunol; 2020 Jul; 146(1):55-57. PubMed ID: 32470485
    [No Abstract]   [Full Text] [Related]  

  • 19. General health status of children with asthma during the COVID-19 pandemic.
    Hepkaya E; Kilinc AA; Cebi MN; Koyuncu Z; Cokugras H
    Pediatr Int; 2021 Mar; 63(3):331-337. PubMed ID: 32881185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital severe COVID-19 in a philanthropic tertiary hospital setting: is asthma a concern? A retrospective study.
    Rojas GA; Ost FN; Stirbulov R; Simões O
    Sao Paulo Med J; 2022; 140(5):651-657. PubMed ID: 35920529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.